Identità

N-Nitroso Zolmitriptan

Non indicato · C16H20N4O3

01Identità

Lazychem IDLC-22552
CAS RNNon indicato
PubChem CID169444811
Molecular formulaC16H20N4O3
Molecular weight316.36 g/mol
IUPAC name(S)-4-((3-(2-(Dimethylamino)ethyl)-1-nitroso-1H-indol-5-yl)methyl)oxazolidin-2-one
InChIKeyOMADIQPUYMATRS-ZDUSSCGKSA-N

02Struttura e stereochimica

2D structurePubChem CID 169444811
Two-dimensional chemical structure of N-Nitroso Zolmitriptan
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains an N-nitroso substructure. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count3
Secondary amines0
Tertiary amines1
SMILESCN(C)CCC1=CN(C2=C1C=C(C=C2)C[C@H]3COC(=O)N3)N=O
InChINon indicato

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Stato in India

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomi e relazioni

API e farmaco progenitore

Zolmitriptan

Impurezze e composti correlati

Nomi e relazioni

    Impurezze e composti correlati

    06Fonti